Day One Announces Oversubscribed $175.0 Million Private Placement

July 30, 2024

https://www.globenewswire.com/news-release/2024/07/30/2920845/0/en/Day-One-Announces-Oversubscribed-175-0-Million-Private-Placement.html

BRISBANE, Calif., July 30, 2024 (GLOBE NEWSWIRE) — Day One Biopharmaceuticals, Inc. (Nasdaq:DAWN) (“Day One” or the “Company”), a commercial-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases, today announced it has entered into a securities purchase agreement for an oversubscribed private placement of its securities for gross proceeds of approximately $175.0 million, before deducting placement agent fees and other expenses.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.